TechTaffy

tech:

taffy

NextCode Health Raises $15M

By TechTaffy Desk

NextCode Health, a private company enabling accelerated diagnosis of genetic diseases through the use of sequence data, has raised $15 million in Series A financing from Polaris Partners and Arch Venture Partners.

The company has also secured an exclusive license for sequence-based clinical diagnostic applications using technology developed by Decode Genetics, including IT infrastructure and data analysis capabilities.

NextCode Health is a sequence-based clinical diagnostics company that offers a solution to genome interpretation and big data challenges, using technology developed over more than 16 years at Decode Genetics, a biopharmaceutical company based in Reykjavík, Iceland.

Just in

Fundings

Rivos raises $250M

Santa Clara, Calif.-based Rivos, a RISC-V accelerated platform company focusing on data analytics and Generative AI, has raised $250 million in its Series A-3 funding round
Industry

IBM, Canada, and Quebec invest $137M to strengthen semiconductor industry

IBM, the Government of Canada, and the Government of Quebec announced agreements to develop the assembly, testing and packaging capabilities for semiconductor modules at IBM Canada's plant in Bromont, Quebec.
Around the web

Net neutrality is back: U.S. promises fast, safe and reliable internet for all — NPR

Consumers can look forward to faster, safer and more reliable internet connections under the promises of newly reinstated government regulations, writes Emma Bowman of NPR.
AI

AI is ‘a new kind of digital species,’ Microsoft AI chief says — Quartz

Mustafa Suleyman, chief executive of Microsoft AI, said during a talk at TED 2024 that AI is the newest wave of creation since the start of life on Earth, and that “we are in the fastest and most consequential wave ever,” writes Britney Nguyen in Quartz.
Around the web

It’s baaack! Microsoft and IBM open source MS-DOS 4.0 — ZDNet

Microsoft and IBM have joined forces to open-source the 1988 operating system MS-DOS 4.0 under the MIT License, writes Steven Vaughan-Nichols.